University of New South Wales: The Altair Study

Project Timeline

November 2006 – November 2011

Antiretroviral therapy is complicated by drug interactions and contraindications. Novel regimens are needed.

This open label study randomly assigned treatment-naive, human immunodeficiency virus (HIV)—infected subjects to receive tenofovir-emtricitabine with efavirenz (Arm I), with ritonavir-boosted atazanavir (Arm II), or with zidovudine/abacavir (Arm III). Pair-wise comparisons of differences in time-weighted mean change from baseline plasma HIV-RNA to week 48 formed the primary analysis. Treatment arms were noninferior if the upper limit of the 95% confidence interval (CI) was <0.5 log10 copies/mL. Secondary objectives included virologic, immunologic and safety end points.

External Links


Other Completed Projects

Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: Correlations between clinical, phenotypic, genotypic characteristics and mortality in a tertiary teaching hospital in Malaysia
Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is a serious infection that can result in significant morbidity and mortality. A retrospective cohort study was conducted to determine the predictors of mortality in...
A Novel Community Healthcare Service Delivery Model For Fishermen Who Use Drugs In Kuantan, Pahang: An Implementation Science Research
It has been estimated that there are 170,000 people who inject drugs (PWID) in Malaysia. HIV prevalence among PWID in Malaysia ranges from 25 % to 45 %. Further, people...
Malaysian AIDS Council: Baseline Assessment for Community Action on Harm Reduction
Community Action on Harm Reduction project, implemented by the Alliance with support of the Ministry of Foreign Affairs of the government of the Netherlands (as a project number 23389), started...